Comments

MoonLake

MLTXNASDAQ
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$44.74
00.00%
After Hours: Jul 19, 4:00 PM EDT
15 minutes delayed
MoonLake (MLTX) ForecastNewsEarningsGuidanceDividends

Analyst Ratings

Insider TradesShort Interest
Consensus Rating1
Buy
Highest Price Target1
$104.00
Lowest Price Target1
$16.00
Consensus Price Target1
$65.23

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

MoonLake (NASDAQ:MLTX) Stock, Analyst Ratings, Price Targets, Forecasts

MoonLake Immunotherapeutics has a consensus price target of $65.23 based on the ratings of 15 analysts. The high is $104 issued by Oppenheimer on June 25, 2024. The low is $16 issued by Jefferies on November 11, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co., Oppenheimer, and HC Wainwright & Co. on July 1, 2024, June 25, 2024, and June 11, 2024, respectively. With an average price target of $101.33 between HC Wainwright & Co., Oppenheimer, and HC Wainwright & Co., there's an implied 126.49% upside for MoonLake Immunotherapeutics from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Apr
0
0
0
0
May
1
Jun
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.8
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer
Needham
Goldman Sachs
Wedbush

1calculated from analyst ratings

Analyst Ratings for MoonLake

Buy NowGet Alert
07/01/2024Buy Now123.51%HC Wainwright & Co.
Raghuram Selvaraju
$100 → $100ReiteratesBuy → BuyGet Alert
06/25/2024Buy Now132.45%Oppenheimer
Andreas Argyrides
 → $104Initiates → OutperformGet Alert
06/11/2024Buy Now123.51%HC Wainwright & Co.
Raghuram Selvaraju
$100 → $100ReiteratesBuy → BuyGet Alert
06/10/2024Buy Now47.52%Needham
Serge Belanger
$66 → $66ReiteratesBuy → BuyGet Alert
05/17/2024Buy Now123.51%HC Wainwright & Co.
Raghuram Selvaraju
 → $100ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now47.52%Needham
Serge Belanger
 → $66ReiteratesBuy → BuyGet Alert
05/08/2024Buy Now123.51%HC Wainwright & Co.
Raghuram Selvaraju
 → $100ReiteratesBuy → BuyGet Alert
04/23/2024Buy Now123.51%HC Wainwright & Co.
Raghuram Selvaraju
 → $100ReiteratesBuy → BuyGet Alert
04/11/2024Buy Now123.51%HC Wainwright & Co.
Raghuram Selvaraju
 → $100ReiteratesBuy → BuyGet Alert
04/09/2024Buy Now47.52%Needham
Serge Belanger
 → $66ReiteratesBuy → BuyGet Alert
04/02/2024Buy Now38.58%Goldman Sachs
Richard Law
 → $62Initiates → NeutralGet Alert
03/13/2024Buy Now105.63%Wedbush
Andreas Argyrides
 → $92ReiteratesOutperform → OutperformGet Alert
03/11/2024Buy Now105.63%Wedbush
Andreas Argyrides
 → $92ReiteratesOutperform → OutperformGet Alert
03/11/2024Buy Now123.51%HC Wainwright & Co.
Raghuram Selvaraju
$75 → $100MaintainsBuyGet Alert
03/11/2024Buy Now47.52%Needham
Serge Belanger
 → $66ReiteratesBuy → BuyGet Alert
03/04/2024Buy Now67.64%HC Wainwright & Co.
Raghuram Selvaraju
 → $75ReiteratesBuy → BuyGet Alert
03/01/2024Buy Now105.63%Wedbush
Andreas Argyrides
 → $92ReiteratesOutperform → OutperformGet Alert
03/01/2024Buy Now47.52%Needham
Serge Belanger
 → $66ReiteratesBuy → BuyGet Alert
02/15/2024Buy Now—Wolfe Research
Andy Chen
—Initiates → OutperformGet Alert
12/18/2023Buy Now54.22%Stifel
Alex Thompson
$66 → $69MaintainsBuyGet Alert
12/08/2023Buy Now60.93%Citigroup
Samantha Semenkow
 → $72Initiates → BuyGet Alert
12/01/2023Buy Now105.63%Wedbush
Andreas Argyrides
 → $92ReiteratesOutperform → OutperformGet Alert
11/27/2023Buy Now67.64%HC Wainwright & Co.
Raghuram Selvaraju
 → $75ReiteratesBuy → BuyGet Alert
11/16/2023Buy Now105.63%Wedbush
Andreas Argyrides
$86 → $92MaintainsOutperformGet Alert
11/15/2023Buy Now72.11%Guggenheim
Yatin Suneja
$70 → $77MaintainsBuyGet Alert
11/08/2023Buy Now74.34%Cantor Fitzgerald
Prakhar Agrawal
 → $78ReiteratesOverweight → OverweightGet Alert
11/07/2023Buy Now92.22%Wedbush
Andreas Argyrides
 → $86ReiteratesOutperform → OutperformGet Alert
11/06/2023Buy Now92.22%Wedbush
Andreas Argyrides
 → $86ReiteratesOutperform → OutperformGet Alert
11/02/2023Buy Now65.4%Stifel
Alex Thompson
 → $74Initiates → BuyGet Alert
10/16/2023Buy Now92.22%Wedbush
Andreas Argyrides
 → $86ReiteratesOutperform → OutperformGet Alert
10/16/2023Buy Now69.87%Needham
Serge Belanger
 → $76ReiteratesBuy → BuyGet Alert
10/03/2023Buy Now92.22%Wedbush
Andreas Argyrides
 → $86ReiteratesOutperform → OutperformGet Alert
09/18/2023Buy Now45.28%Cantor Fitzgerald
Prakhar Agrawal
 → $65ReiteratesOverweight → OverweightGet Alert
09/18/2023Buy Now92.22%Wedbush
Andreas Argyrides
 → $86ReiteratesOutperform → OutperformGet Alert
09/14/2023Buy Now45.28%Cantor Fitzgerald
Prakhar Agrawal
 → $65ReiteratesOverweight → OverweightGet Alert
09/12/2023Buy Now31.87%Barclays
Leon Wang
$41 → $59MaintainsEqual-WeightGet Alert
09/12/2023Buy Now45.28%Cantor Fitzgerald
Prakhar Agrawal
 → $65ReiteratesOverweight → OverweightGet Alert
09/12/2023Buy Now67.64%HC Wainwright & Co.
Raghuram Selvaraju
 → $75ReiteratesBuy → BuyGet Alert
09/12/2023Buy Now69.87%Needham
Serge Belanger
 → $76ReiteratesBuy → BuyGet Alert
08/31/2023Buy Now69.87%Needham
Serge Belanger
 → $76Initiates → BuyGet Alert
08/14/2023Buy Now92.22%Wedbush
Andreas Argyrides
 → $86ReiteratesOutperform → OutperformGet Alert
08/14/2023Buy Now67.64%HC Wainwright & Co.
Raghuram Selvaraju
 → $75ReiteratesBuy → BuyGet Alert
07/31/2023Buy Now92.22%Wedbush
Andreas Argyrides
$61 → $86MaintainsOutperformGet Alert
07/26/2023Buy Now67.64%HC Wainwright & Co.
Raghuram Selvaraju
 → $75ReiteratesBuy → BuyGet Alert
07/17/2023Buy Now67.64%HC Wainwright & Co.
Raghuram Selvaraju
$37 → $75MaintainsBuyGet Alert
07/03/2023Buy Now45.28%Cantor Fitzgerald
Prakhar Agrawal
$29 → $65MaintainsOverweightGet Alert
06/27/2023Buy Now-8.36%Barclays
Leon Wang
$28 → $41MaintainsEqual-WeightGet Alert
06/26/2023Buy Now45.28%Guggenheim
Yatin Suneja
$51 → $65MaintainsBuyGet Alert
06/21/2023Buy Now-17.3%HC Wainwright & Co.
Raghuram Selvaraju
 → $37ReiteratesBuy → BuyGet Alert
06/15/2023Buy Now-37.42%Barclays
Leon Wang
 → $28Initiates → Equal-WeightGet Alert
05/15/2023Buy Now-17.3%HC Wainwright & Co.
Raghuram Selvaraju
 → $37ReiteratesBuy → BuyGet Alert
05/10/2023Buy Now-17.3%HC Wainwright & Co.
Raghuram Selvaraju
$30 → $37Reiterates → BuyGet Alert
05/04/2023Buy Now-32.95%HC Wainwright & Co.
Raghuram Selvaraju
 → $30Reiterates → BuyGet Alert
05/01/2023Buy Now13.99%Guggenheim
Yatin Suneja
 → $51Initiates → BuyGet Alert
04/20/2023Buy Now-32.95%HC Wainwright & Co.
Raghuram Selvaraju
$28 → $30MaintainsBuyGet Alert
03/22/2023Buy Now-26.24%Wedbush
Andreas Argyrides
 → $33Initiates → OutperformGet Alert
03/21/2023Buy Now-37.42%HC Wainwright & Co.
Raghuram Selvaraju
 → $28Reiterates → BuyGet Alert
03/20/2023Buy Now-35.18%Cantor Fitzgerald
Prakhar Agrawal
$23 → $29MaintainsOverweightGet Alert
03/09/2023Buy Now-19.54%BTIG
Julian Harrison
 → $36Initiates → BuyGet Alert
03/06/2023Buy Now-48.59%Cantor Fitzgerald
Prakhar Agrawal
 → $23Reiterates → OverweightGet Alert
02/14/2023Buy Now-48.59%Cantor Fitzgerald
Prakhar Agrawal
 → $23Initiates → OverweightGet Alert
02/13/2023Buy Now-37.42%HC Wainwright & Co.
Raghuram Selvaraju
 → $28Reiterates → BuyGet Alert
02/03/2023Buy Now-37.42%HC Wainwright & Co.
Raghuram Selvaraju
 → $28Reiterates → BuyGet Alert
11/11/2022Buy Now-64.24%Jefferies
Kelly Shi
 → $16Initiates → BuyGet Alert
08/25/2022Buy Now-62%SVB Leerink
Thomas Smith
 → $17Initiates → OutperformGet Alert
07/21/2022Buy Now-37.42%HC Wainwright & Co.
Raghuram Selvaraju
 → $28Initiates → BuyGet Alert
07/07/2022Buy Now—Cowen & Co.
Phil Nadeau
—Initiates → OutperformGet Alert

FAQ

Q

What is the target price for MoonLake (MLTX) stock?

A

The latest price target for MoonLake (NASDAQ:MLTX) was reported by HC Wainwright & Co. on July 1, 2024. The analyst firm set a price target for $100.00 expecting MLTX to rise to within 12 months (a possible 123.51% upside). 44 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for MoonLake (MLTX)?

A

The latest analyst rating for MoonLake (NASDAQ:MLTX) was provided by HC Wainwright & Co., and MoonLake reiterated their buy rating.

Q

When was the last upgrade for MoonLake (MLTX)?

A

There is no last upgrade for MoonLake

Q

When was the last downgrade for MoonLake (MLTX)?

A

There is no last downgrade for MoonLake.

Q

When is the next analyst rating going to be posted or updated for MoonLake (MLTX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MoonLake, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MoonLake was filed on July 1, 2024 so you should expect the next rating to be made available sometime around July 1, 2025.

Q

Is the Analyst Rating MoonLake (MLTX) correct?

A

While ratings are subjective and will change, the latest MoonLake (MLTX) rating was a reiterated with a price target of $100.00 to $100.00. The current price MoonLake (MLTX) is trading at is $44.74, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch